Eterna Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Historical Holders from Q4 2022 to Q1 2025

Symbol
ERNA on Nasdaq
CUSIP
114082209
Type / Class
Equity / Common Stock, par value $0.005 per share
Shares outstanding
62.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
994K
Holdings value
$292K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
24
Number of buys
8
Number of sells
-8
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Eterna Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cherington Charles 32.8% $5.31M 20.4M Charles Cherington Apr 2, 2025
Freebird Partners LP 9.99% $1.34M 5.14M Freebird Partners LP Oct 29, 2024
HALPERN JOHN D 9.99% $1.34M 5.14M John D. Halpern Oct 29, 2024
IAF, LLC 5.22% $697K 2.68M IAF, LLC Oct 29, 2024
Singer Nicholas Jason 4.92% $667K 2.57M Nicholas Jason Singer Dec 31, 2024

Institutional Holders of Eterna Therapeutics Inc. - Common Stock, par value $0.005 per share (ERNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 94.4K $16.8K $0.18 1
2024 Q4 994K $292K +$69.7K $0.29 24
2024 Q3 711K $747K +$337K $1.05 20
2024 Q2 390K $712K -$25K $1.83 19
2024 Q1 10.2K $25.3K +$25.1K $2.40 4
2023 Q4 355K $637K +$42.2K $1.80 18
2023 Q3 331K $728K -$4.86K $2.18 19
2023 Q2 333K $750K -$15.6K $2.26 19
2023 Q1 332K $1.14M +$6.9K $3.40 19
2022 Q4 250K $805K +$608K $3.22 17